Baby formula out-of-stock rate increased to over 73% nationwide by end of May
The out-of-stock rate for baby formula continues to rise as companies, including Abbott Nutrition, work to get the critical product in the hands of parents across the nation.
Abbott's Michigan baby formula plant reopens: How long before parents see more supply?
Baby formula manufacturer Abbott will make more formula available to consumers beginning June 20.
Adult bed rails sold at Walmart, Amazon, eBay linked to multiple deaths, feds say
The U.S. Consumer Product Safety Commission (CPSC) is calling on consumers to "immediately stop using" 285,000 Mobility Transfer Systems adult portable bed rails that have been linked to three deaths.
Oracle’s $28.3B Cerner deal near after regulatory hurdles cleared
Oracle expects to complete its $95 per share tender offer for Cerner on June 6 paving the way for the company's largest acquisition ever.
Abbott to reopen Michigan facility on June 4, prioritize production of specialty formula
Abbott said Tuesday that it will prioritize production of its EleCare specialty amino acid-based formulas, which are for babies with allergic and digestive disorders, when the Sturgis facility reopens.
Moderna testing potential monkeypox vaccines
Moderna Inc. is currently testing a potential monkeypox vaccine in pre-clinical trials as case numbers continue to rise in both the United States and Europe.
Salmonella outbreak: Jif peanut butter recall expanded
Cargill's voluntary recall includes certain lots of its Milk and Dark Chocolate Covered Peanut Butter Ritz Crackers, Peanut Butter Meltaways, Peanut Butter Eggs and Fudge, according to the recall notice posted by the U.S. Food and Drug Administration.
Baby formula shortage: Out-of-stock rate hits 45% nationwide in May
In April, the data showed that baby formula shortages hit 30% before jumping to 40% at the end of the month. By early May, the out-of-stock rate rose to 43%.
Baby formula shortage: Danone ramps up shipments to US
Danone said it recognizes the importance of these specialized formulas and has made it its priority to "increase production and supply since the shortages arose in February.”
FDA chief grilled on baby formula crisis, delivers mixed message
On Thursday, Robert Califf said Abbott’s Michigan formula plant could be up and running by next week, but skirted questions about whether the FDA should have addressed problems at the facility sooner.
New York Times delays staff return to office due to COVID-19 hikes
The New York Times previously expected its employees to return to office in June but COVID-19 spikes have delayed the return to the NYC office.
Baby formula shortage: Changes Abbott made ahead of Michigan plant restart
Abbott initially issued a voluntary recall of certain powdered formulas made at its Sturgis facility after four complaints that babies who consumed products from the plant became sick from bacterial infections. Two of the infants died.
Newly FDA-registered baby formula maker offers solution to ‘unfathomable’ shortage
ByHeart CEO Ron Belldegrun says its FDA-registered, American-made baby formula can serve as a "solution" to the national "crisis."
Baby formula shortage: Physician's tips for parents in need
Parents who need specialty formula should consult a pediatrician first. It will be faster than if a patient tries to contact the manufacturer directly.
J&J names executives of planned Tylenol, Band-Aid company
The current head of Johnson & Johnson's consumer-health division will helm the business after J&J turns it into a stand-alone company.
Chip shortage a ‘very real, critical’ health care challenge: Hologic CEO
Hologic CEO Stephen MacMillan warns the microchips shortage has created "unintended consequences" for the health care industry and its patients.
Pfizer to buy rest of Biohaven for $11.6B
Pfizer Inc. agreed to buy the rest of Biohaven Pharmaceutical Holding Co. for about $11.6 billion, deploying its pile of cash earned from Covid-19 sales to acquire a new migraine drug.
Judge to decide how much pharmacies owe over opioid crisis
Back in November, a jury in U.S. District Judge Dan Polster’s courtroom sided with the counties and agreed that the way the pharmacies dispensed pain medication played an outsized role in creating a public nuisance.
LA healthcare workers begin 5-day strike over alleged unfair labor practices at Cedars-Sinai Medical Center
Hundreds of healthcare workers kicked off a planned 5-day strike Monday morning in front of Cedars-Sinai hospital to protest what they allege are “unfair labor practices, short staffing, and high patient infection rates.”
FDA approves marketing for new Alzheimer's early detection test
The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline.


















